Growth Marketing Strategies for the Healthcare Industry

A defensible growth program in behavioral health runs on four inputs, and they operate in sequence. Substantiated message comes first. Every objective claim on a hero, service page, or paid ad needs competent and reliable scientific evidence behind it, because the FTC treats implied outcome language the same as an express promise ^{1, 2}. Copy that cannot survive that test drags the whole funnel down, no matter how well the media is bought.

Comprehensible journey comes second. Organizational health literacy, as ODPHP defines it, is the degree to which an organization enables people to find, understand, and use its information and services ³. That is a conversion variable disguised as a policy term. If a family decision-maker cannot follow the eligibility question or the VOB form, the ad worked and the intake still fails.

Trust-weighted channel selection comes third. The 2025 systematic review on trust in digital healthcare identifies human interaction, privacy, data accuracy, quality, and satisfaction as the factors shaping consumer trust ¹⁵. Channel mix should be weighted against those drivers, not against reach alone.

Admissions-grade measurement closes the loop. NCI’s planning guide frames health communication as an evaluation discipline: audience analysis, message testing, channel selection, and measurement against defined outcomes ⁷.

The leaks are predictable, and they cluster in three places. The first is the substantiation gap on the landing page. Hero copy makes an implied recovery-rate promise, a testimonial reinforces it, and no file in the marketing folder maps that language to competent and reliable evidence ². Paid media pushes traffic into that page for months before anyone audits it.

The second is the comprehension gap between the ad and the intake call. AHRQ’s engagement research identifies limited health or tech literacy, user-friendliness, privacy concerns, and disparities as recurring barriers to digital engagement ¹². Those barriers show up inside admissions funnels as abandoned VOB forms, missed callback windows, and family decision-makers who never advance past a first inquiry because the next step was never explained in language they could act on.

The third is the measurement gap. Programs count sessions, clicks, and form fills. They rarely instrument whether the family decision-maker understood the eligibility answer, whether the intake coordinator confirmed comprehension, or whether the portal handoff completed. Without those checkpoints, CMOs cannot tell whether cost per admission rose because of media inflation, message failure, or journey friction. Each of those has a different fix.

The FTC does not distinguish between what a landing page says outright and what it lets a reader infer. Both count as claims, and both need competent and reliable scientific evidence before the copy goes live ². A hero that reads “lasting recovery starts here” is not a slogan in regulatory terms. It is an implied outcome claim, and the standard for substantiation is the same one that applies to an express recovery-rate percentage.

Outcome-oriented copy on treatment center sites tends to cluster in four places: the hero line, the program description, the testimonial pull-quote, and the trust-badge subhead. Each is an FTC surface. The agency has been consistent that objective claims about health results must be truthful, not misleading, and adequately substantiated at the moment they are disseminated ^{1, 2}. Retroactive documentation does not satisfy the standard.

The practical implication for CMOs is narrow. Any language that a reasonable family decision-maker would read as a promise about clinical results, relapse likelihood, program effectiveness, or comparative outcomes belongs in a substantiation review before it enters the media plan. That review should treat testimonial copy the same as headline copy, because implied claims carried by a patient story are still claims the advertiser is making.

A substantiation file is a working document, not a legal archive. It maps every objective claim on the site and in active ad copy to the specific evidence supporting it, at the level the FTC describes as competent and reliable scientific evidence ². The file lives with the marketing team, gets reviewed on the same cadence as creative refresh, and is legible to the intake coordinator who may be asked by a caller to explain what a headline means.

Three columns cover most of the work:

• The first lists the exact claim language, including implied claims carried by imagery or testimonials.
• The second names the evidence: peer-reviewed studies, internal outcomes data with a documented methodology, or accreditation records.
• The third records the reviewer, the date, and the disposition, so a claim that loses its evidentiary basis gets pulled rather than grandfathered ¹.

Two guardrails matter operationally. OCR has warned that its own materials are not endorsements or certifications of private consultants or systems, so “HIPAA-certified” or similar language on a landing page is itself a misleading claim risk ¹¹. And any comparative language against other facilities needs evidence at the same standard as absolute claims ².

Comprehension is a conversion variable, and it can be instrumented at four specific points in the admissions funnel: the landing page hero, the eligibility question, the VOB form, and the first admissions call. AHRQ’s Universal Precautions Toolkit recommends chunk-and-check, which breaks information into smaller segments and confirms understanding before moving on, and teach-back, which asks the person to restate what they heard in their own words ⁶. Both methods were developed for clinical settings. Both translate directly into growth marketing operations.

On the landing page hero, chunk-and-check becomes a copy discipline. One idea per block, one action per screen, and a subhead that restates the promise in plainer language than the headline uses. CDC’s plain-language guidance reinforces this, framing user-centered and participatory design as methods that raise comprehension and acceptance rather than aesthetic preferences ⁵. On the eligibility question, the same principle means asking one thing at a time and confirming the answer before the form advances.

The VOB form is where chunk-and-check pays back the fastest. A family decision-maker abandons the form when a question introduces two variables at once, such as policy holder identity and coverage type in the same field. Splitting those, and confirming each answer inline, converts.

Teach-back belongs on the first admissions call. Intake coordinators can be trained to ask the caller to repeat the next step in their own words before the call ends ⁶. That single behavior surfaces the misunderstandings that would otherwise become missed callbacks. The comprehension checkpoint becomes a leading indicator the CMO can track: percentage of intake calls where teach-back was completed, and the callback rate that follows.

AHRQ’s engagement research names four recurring barriers to digital engagement: limited health or tech literacy, user-friendliness, privacy concerns, and disparities ¹². Each barrier maps to a specific stage of the admissions funnel, and each produces a drop-off pattern a CMO can measure without adding clinical overhead.

• Limited health or tech literacy shows up earliest, at the traffic-to-inquiry stage. A landing page written above a ninth-grade reading level or an intake form that asks for insurance jargon before asking for a name filters out the family decision-makers most likely to place the call.
• User-friendliness shows up at the inquiry-to-VOB stage. A form that requires a portal login to submit, or a scheduler that fails on mobile, converts qualified interest into abandonment.
• Privacy concerns show up at the VOB-to-admission stage, when a caller is asked to disclose sensitive information without a clear explanation of how it will be used or protected.
• Disparities show up across all stages, and they compound: a journey that assumes broadband, English fluency, and a shared device history will lose share unevenly across the payer mix.

The operational move is to instrument each barrier as a checkpoint: portal completion rate, form-field abandonment by question, callback rate after privacy language is shown, and mobile-versus-desktop conversion by geography. A supporting evidence base includes a study of 247 patients that found eHealth literacy positively associated with portal use and interest in health-tracking tools, and a systematic review that found people with limited health literacy are often less likely to use patient portals, though the review noted results were not perfectly consistent across studies ^{13, 14}. Onboarding support and simplified digital journeys are the corrective, not more traffic.

Reach is the wrong first question. The 2025 systematic review of consumer and professional trust in digital healthcare identifies eight factors that shape whether a prospective patient trusts a digital touchpoint enough to act on it: human interaction, privacy concerns, data accuracy, digital literacy, quality, satisfaction, education, and income ¹⁵. Those factors give CMOs a defensible priority order for channel investment, one that survives a CEO review because it is not built on vendor benchmarks.

The practical read is that channels enabling direct human interaction, protecting privacy visibly, and delivering accurate information carry more weight per dollar than channels optimized purely for impression volume. A call-forward search campaign that routes to a trained intake coordinator ranks higher than a display network buying attention at scale. A branded organic result that leads to a page with clear privacy language ranks higher than a remarketing sequence that follows a family decision-maker across the web without explanation.

Digital literacy and education sit in the same list, which means channel choices interact with the audience’s ability to use them. A texting workflow that assumes fluent digital literacy will underperform against the same population reached by a phone number placed above the fold. The review frames trust as multi-factor and context-dependent, so channel mix should be weighted rather than ranked absolutely ¹⁵.

Human-in-the-loop channels earn priority as a result. Paid search paired with a live-answered phone line. Organic content that ends with a named clinician or intake coordinator, not a generic form. Chat that hands off to a person within one exchange rather than looping through scripted prompts. Each of these preserves the human signal the family decision-maker is looking for before disclosing sensitive information.

The corollary is that fully automated funnels underperform in this segment even when their cost per lead looks favorable. A form-only inquiry path may lower acquisition cost on paper and raise cost per admission in practice, because the family never got the human confirmation the trust research says they need ¹⁵. Track cost per admissions call, not cost per form fill.

HIPAA defines marketing as a communication that encourages the recipient to purchase or use a product or service, and OCR requires written authorization before using or disclosing protected health information for most marketing purposes ^{8, 9}. The definition is narrower than many CMOs assume, and the operational boundary matters. Communication about the individual’s own treatment, care coordination, or case management is not marketing under the Privacy Rule. Communication that promotes a third party’s product, or that uses PHI to target promotional messages, generally is.

HHS has stated that authorization is required for all marketing communications except two narrow circumstances: face-to-face communication with the individual, and a promotional gift of nominal value ¹⁰. Everything else that meets the marketing definition and uses PHI requires prior written authorization. That includes email sequences segmented by diagnosis, direct mail using treatment history, and any campaign where a third party pays the covered entity to make the communication.

One additional guardrail sits alongside the definition. OCR has warned that its materials are not endorsements or certifications of private consultants or systems, so any landing page or brochure that claims HIPAA endorsement or certification is itself a compliance exposure ¹¹. The correct framing describes the practices in place, not a nonexistent federal seal.

Remarketing pixels that fire on pages containing PHI, or that build audiences from identifiable health information, sit inside the HIPAA marketing definition and require authorization before disclosure to the ad platform ^{8, 9}. Pixels loaded on a general homepage or non-clinical blog post fall outside that boundary. Segmenting the site by page type, and gating pixel deployment accordingly, keeps the remarketing program running without triggering an authorization requirement it cannot satisfy.

Email programs follow the same logic. A newsletter sent to a general subscriber list built from public opt-ins is not HIPAA marketing. An email sent to former patients using treatment history to select the audience is, and needs authorization ¹⁰. The operational move is to keep marketing lists separate from patient records, with documented consent language for the marketing list.

Referral programs raise a separate FTC issue. Any implied outcome claim in referral partner copy is an advertiser claim, and the treatment center carries the substantiation obligation regardless of who wrote the sentence ^{1, 2}. Referral partner materials belong inside the same substantiation review as owned media.

Session counts and form fills tell a CMO whether media bought attention. They do not answer whether the family decision-maker understood what to do next, which is the variable that predicts admissions. NCI’s planning framework treats measurement as an evaluation discipline built around defined outcomes, not around traffic totals ⁷. Applied to an admissions funnel, that means every stage carries a comprehension checkpoint alongside a conversion metric.

Four checkpoints cover most of the funnel:

• On the landing page, track scroll depth against the plain-language subhead rather than the hero, because the subhead is where CDC’s plain-language standard does the comprehension work ⁵.
• On the eligibility question, track field-level abandonment and the rate at which callers ask an intake coordinator to re-explain a term.
• On the VOB form, track completion by question, not just by form.
• On the first admissions call, track teach-back completion: the percentage of calls where the coordinator asked the caller to restate the next step in their own words ⁶.

Report those four alongside cost per admissions call. When cost per admission rises, the checkpoint data isolates whether the failure sits in message, journey, or channel, and each has a different corrective.

For CMOs running growth across a portfolio of facilities, the operating model has to survive local variation. Payer mix, licensure, and program design differ by site, but the growth inputs that determine whether a funnel compounds are the same across the portfolio. The table below maps each input to the funnel stage it most affects and the sourced barrier or requirement driving it. Use it as a governance checklist for multi-facility rollouts, not as a scoring rubric.

Two governance moves matter at the portfolio level. Substantiation files should be centralized so a claim retired at one facility does not resurface on another site’s landing page ². And usability audits should be run per facility rather than at the brand level, because the AHRQ barrier taxonomy interacts with local payer mix and device patterns ¹². A single national audit will miss the disparities that show up unevenly across sites.